Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial nitroreductases are flavin-dependent oxidoreductase enzymes that catalyze the reduction of nitroaromatic and nitroheterocyclic compounds. They are involved in prodrug activation, converting inert compounds into active drugs, and can also contribute to antimicrobial resistance. NTRs operate via a ping-pong bi-bi redox mechanism using NADH/NADPH as electron donors. They are classified as Type I (oxygen-insensitive) or Type II (oxygen-sensitive). Their activity is exploited in gene-directed enzyme prodrug therapy (GDEPT) for cancer treatment.
Reductive activation of nitro-containing prodrugs, releasing active metabolites or cytotoxic species.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Nitroreductase (NTR).